MYC and lymphoma: This finding is consistent with the fact that at the B-cell differentiation stage to which peripheral lymphomas corresponded, activity of only the hs1,2 and 3a enhancers was not sufficient to drive deregulated Myc expression in Igh/Myc translocation-positive precursors [21].